A detailed history of Ameriprise Financial Inc transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Ameriprise Financial Inc holds 10,414 shares of WVE stock, worth $112,575. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,414
Holding current value
$112,575
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$8.0 - $16.44 $83,312 - $171,206
10,414 New
10,414 $128,000
Q2 2024

Aug 14, 2024

SELL
$4.38 - $6.48 $1,533 - $2,268
-350 Reduced 1.33%
25,994 $129,000
Q1 2024

May 15, 2024

BUY
$3.54 - $6.84 $1,221 - $2,359
345 Added 1.33%
26,344 $162,000
Q4 2023

Feb 14, 2024

BUY
$4.16 - $6.87 $108,155 - $178,613
25,999 New
25,999 $131,000
Q2 2018

Aug 14, 2018

SELL
$33.85 - $50.65 $796,016 - $1.19 Million
-23,516 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$32.45 - $54.7 $763,094 - $1.29 Million
23,516 New
23,516 $943,000

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $939M
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.